Arsil%252525252525252525252525252525252525252525252525252525252525252525252520dx

# Arsil-dx (Dextromethorphan/Chlorpheniramine/Phenylephrine) ## Overview Arsil-dx is a multi-ingredient over-the-counter (OTC) combination product used for the temporary relief of upper respiratory symptoms. It typically contains **Dextromethorphan** (antitussive), **Chlorpheniramine** (first-generation antihistamine), and **Phenylephrine** (nasal decongestant). ## Primary Indications * Temporary relief of cough due to minor throat/bronchial irritation. * Relief of sneezing, runny nose, and nasal congestion associated with the common cold or allergic rhinitis. ## Adult Dosing * **Standard Formulation:** Usually 10 mL (or 1 dose unit) every 4–6 hours as needed. * **Maximum:** Do not exceed 4 doses in 24 hours. Follow specific product labeling as concentrations vary by manufacturer. ## Pediatric Dosing * **Children < 4 years:** Generally contraindicated/not recommended due to lack of efficacy and safety concerns regarding medication errors and adverse events. * **Children 4–12 years:** Use only per specific pediatric labeling; usually half the adult dose. * **Note:** Use calibrated measuring device provided with the product. Do not use kitchen spoons. ## Dose Adjustments * **Renal/Hepatic Impairment:** No specific manufacturer guidelines, but caution is advised in patients with severe impairment; consult a physician for individual dose titration. ## Contraindications * Hypersensitivity to any component. * Concurrent use of Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping an MAOI. * Severe hypertension or severe coronary artery disease. ## Adverse Effects * **CNS:** Drowsiness, dizziness, excitation/nervousness (common in children). * **Cardiovascular:** Elevated blood pressure, tachycardia, palpitations. * **Anticholinergic:** Dry mouth, blurred vision, urinary retention (due to chlorpheniramine). ## Key Drug Interactions * **MAOIs:** Risk of hypertensive crisis or serotonin syndrome. * **CNS Depressants/Alcohol:** Additive sedative effects. * **Antihypertensives:** Phenylephrine may antagonize the effects of blood pressure-lowering medications. ## Monitoring * Monitor blood pressure periodically in patients with pre-existing hypertension. * Assess for excessive sedation or paradoxical excitation (especially in pediatric patients). * Monitor for symptom resolution; discontinue if cough persists > 7 days or is accompanied by high fever. ## Clinical Pearls * **Avoid duplication:** Check other OTC medications (e.g., pain relievers/cold meds) to prevent accidental overdose of acetaminophen or decongestants. * **Sedation:** Advise patients to avoid driving or operating heavy machinery until they know how the product affects them. * **Phenylephrine Efficacy:** Clinical evidence regarding the oral bioavailability and efficacy of oral phenylephrine as a nasal decongestant is limited; expect inconsistent results compared to pseudoephedrine. *** **Educational Disclaimer:** This information is for educational purposes only. Drug formulations, concentrations, and regulatory status can vary significantly by region and manufacturer. Always verify specific dosing, safety warnings, and contraindications via the current product labeling (FDA Drug Labeling Database) or institutional clinical guidance before prescribing or administering medication.